Phase IIb study of eliapixant in refractory chronic cough meets primary efficacy outcome Aug. 4, 2021 No Comments
Wuhan LL Science and Technology Development divulges P2X4 receptor antagonists July 23, 2021 No Comments
BIX-119 leads to improved clinical benefit through blocking both IL-17 and IL-22 July 19, 2021 No Comments
RSS